This is the recording of the regular press briefing of European Medicines Agency on COVID-19 vaccines and therapeutics that took place on 23 September 2021.
00:00 Start
00:08 Introduction
01:18 Update on recent developments (as of 23.09.2021) by Dr. Cavaleri
10:29 Questions from journalists
11:14 Treatments for COVID-19
12:57 Efficacy of COVID-19 vaccines
15:25 Curevac application
16:27 Vaccines and boosters
18:22 Boosters for general population/Vaccines for kids
21:06 Booster shots ingredients
22:55 COVID-19 Vaccines for 5-11 years old children
25:06 Adverse reactions
27:22 Second dose of Janssen vaccine
28:36 Boosters of COVID-19 vaccines
29:59 Boosters for the new variants
30:47 Wrap-up
EMA Speakers:
Marco Cavaleri, Head of Biological Health Threats and Vaccines Strategy
Fergus Sweeney, Head of Clinical Studies and Manufacturing Task Force
Georgy Genov, Head of Pharmacovigilance
EMA Moderator:
Monika Benstetter, Head of Media and Public Relations
#EMAPresser #COVID19
EMA press briefing 23 September 2021
Теги
covid19covid-19emavaccinesEMAPresserpressbriefingjournalistsicknesstreatmentanti-viralvariantconcernprotectionboosterhospitalisationthirddoseshotjabmRNAvectorstrategyvaccinationexposureimmunityregulatordataevidencepopulationeffectivenessevolutionvaccinemix and matchapproachfourth doseJanssenJohnson and JohnsonCurevacsecondaryeffectsadversereactionskidschildrenadolescents